Lentiviral Gene Therapy for Cystic Fibrosis: A Promising Approach and First-in-Human Trial.
Davies JC. et al, (2024), Am J Respir Crit Care Med, 210, 1398 - 1408
A roadmap to precision treatments for familial pulmonary fibrosis.
Hurley K. et al, (2024), EBioMedicine, 104
Novel Buffer Formulations for Improved Recombinant Lentiviral Vector Stability and In Vivo Delivery to the Murine Lungs
Miah KM. et al, (2023), MOLECULAR THERAPY, 31, 760 - 760
Type I interferon receptor signalling deficiency results in dysregulated innate immune responses to SARS-CoV-2 in mice.
Ogger PP. et al, (2022), Eur J Immunol, 52, 1768 - 1775
Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors.
Munday RJ. et al, (2022), Mol Ther Methods Clin Dev, 26, 239 - 252
Correction of a chronic pulmonary disease through lentiviral vector-mediated protein expression.
Lund-Palau H. et al, (2022), Mol Ther Methods Clin Dev, 25, 382 - 391
A High-Throughput Cell Culture Model of Idiopathic Pulmonary Fibrosis (IPF) for Gene Therapy Applications
Cerezuela MP. et al, (2022), MOLECULAR THERAPY, 30, 292 - 292
Development of Passive Immunoprophylaxis Against SARS-CoV-2 Using Elderly and Immunodeficient Mice Models
Du Y. et al, (2022), MOLECULAR THERAPY, 30, 11 - 12
F/HN Pseudotyped Lentiviral Vector Uses Alpha 2,3 Sialylated N-Acetyllactosamine to Efficiently Transduce Human Airway Cells
Munday RJ. et al, (2022), MOLECULAR THERAPY, 30, 12 - 12
SARS-CoV-2 Spike Protein-Pseudotyped Lentiviral Vectors (S-LV) for In Vitro and In Vivo Modelling of Emergent SARS-CoV-2 Variants
Miah KM. et al, (2022), MOLECULAR THERAPY, 30, 384 - 385
Lung directed antibody gene transfer confers protection against SARS-CoV-2 infection.
Du Y. et al, (2022), Thorax
Intranasal Lentiviral Vector-Mediated Antibody Delivery Confers Reduction of SARS-CoV-2 Infection in Elderly and Immunocompromised Mice.
Du Y. et al, (2022), Front Immunol, 13
Preclinical optimisation of lentiviral gene therapy delivery for surfactant deficiencies in piglets
McDougall C. et al, (2022), HUMAN GENE THERAPY, 33, A196 - A196
Aerosol-Mediated Non-Viral Lung Gene Therapy: The Potential of Aminoglycoside-Based Cationic Liposomes.
Le Gall T. et al, (2021), Pharmaceutics, 14
Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
Antepowicz A. et al, (2021), Scientific Reports, 11
Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus
DOWNES D. et al, (2021), Nature Genetics
Genomic diversity of SARS-CoV-2 in Oxford during United Kingdom's first national lockdown.
Munis AM. et al, (2021), Sci Rep, 11
Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus.
Downes DJ. et al, (2021), Nat Genet, 53, 1606 - 1615
RNA-Seq Analysis of the Human Surfactant Air-Liquid Interface Culture Reveals Alveolar Type II Cell-like Transcriptome
Munis AM. et al, (2021), Molecular Therapy - Methods & Clinical Development